Of particular interest was a report showing that miR-130b-3p regulates CD133 + tumour-initiating cells in human hepatocellular carcinoma by targeting TP53INP122, which encodes a downstream component of the p53 signalling pathway. The gene discussed is PROM1; the disease is neoplasm.